Cedar Capital’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-12,232
| Closed | -$976K | – | 99 |
|
|
2020
Q3 | $976K | Buy |
12,232
+3,783
| +45% | +$302K | 0.32% | 87 |
|
|
2020
Q2 | $584K | Buy |
8,449
+673
| +9% | +$46.5K | 0.22% | 100 |
|
|
2020
Q1 | $489K | Sell |
7,776
-225
| -3% | -$14.1K | 0.23% | 98 |
|
|
2019
Q4 | $622K | Buy |
8,001
+1,638
| +26% | +$127K | 0.29% | 111 |
|
|
2019
Q3 | $466K | Buy |
6,363
+1,431
| +29% | +$105K | 0.22% | 122 |
|
|
2019
Q2 | $304K | Sell |
4,932
-276
| -5% | -$17K | 0.13% | 140 |
|
|
2019
Q1 | $332K | Sell |
5,208
-309
| -6% | -$19.7K | 0.15% | 133 |
|
|
2018
Q4 | $282K | Sell |
5,517
-1,185
| -18% | -$60.6K | 0.14% | 132 |
|
|
2018
Q3 | $389K | Buy |
6,702
+2,196
| +49% | +$127K | 0.15% | 138 |
|
|
2018
Q2 | $219K | Buy |
+4,506
| New | +$219K | 0.1% | 143 |
|